The HIV drugs market reached a value of USD 33.54 billion in 2023, demonstrating the importance of ongoing advancements in the treatment and management of HIV. With a projected CAGR of 4.5% from 2024 to 2032, the market is expected to reach USD 49.85 billion by 2032. This growth is driven by technological advancements in antiretroviral […]
Thursday, December 5